| ID | 118990 |
| 著者 |
板東, 浩
Medical Research|Tokushima University|Yoshinogawa Hospital|Japan Low Carbohydrate Diet Promotion Association
KAKEN研究者をさがす
Ogawa, Hiroko
Yoshinogawa Hospital
Urasaki, Hirohisa
Japan Low Carbohydrate Diet Promotion Association|Nankai Hospital
Urasaki, Hiroko
Japan Low Carbohydrate Diet Promotion Association
Nakanishi, Miwako
Yoshinogawa Hospital
Watanabe, Osami
Yoshinogawa Hospital
|
| キーワード | Imeglimin
Twymeeg
Type 2 Diabetes
75g Oral Glucose Tolerance Test
Insulinogenic Index
Japan LCD Promotion Association
|
| 資料タイプ |
学術雑誌論文
|
| 抄録 | Background: Recent pharmacological studies reveal imeglimin (Twymeeg) including dual mechanisms for stimulating insulin secretion and reducing insulin resistance.
Case Presentation: The case is a 62-year-old male with type 2 diabetes (T2D). He showed HbA1c 6.4% and started imeglimin. After 5 weeks, a 75g oral glucose tolerance test (75gOGTT) was conducted, and the biomarkers were compared with that of 6 months ago. Insulinogenic index (IGI) 0-30min was stable, but insulin secretion was increased during 30-60min and 60-120min. Discussion: Previous studies of imeglimin revealed improved insulin secretion for GTT. Clinical progress will be followed up with detailed investigation of glucose and insulin variability. |
| 掲載誌名 |
Asploro Journal of Biomedical and Clinical Case Reports
|
| ISSN | 25820370
|
| 出版者 | Asploro
|
| 巻 | 5
|
| 号 | 3
|
| 開始ページ | 113
|
| 終了ページ | 119
|
| 発行日 | 2022-08-19
|
| 権利情報 | This is an open-access article distributed under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium provided the original work is properly cited.
|
| 出版社版DOI | |
| 出版社版URL | |
| フルテキストファイル | |
| 言語 |
eng
|
| 著者版フラグ |
出版社版
|
| 部局 |
医学系
病院
|
